Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2010
12/02/2010US20100303896 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis
12/02/2010US20100303888 Composition for enhancing bone formation
12/02/2010US20100303871 Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
12/02/2010US20100303822 Polypeptides from non-typeable haemophilus influenzae
12/02/2010US20100303815 METHOD OF TREATING ANEMIA BY ADMINISTERING IL 1ra
12/02/2010US20100303782 Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
12/02/2010US20100303781 Treatment
12/02/2010US20100303774 Methods of using regenerative cells in the treatment of musculoskeletal disorders
12/02/2010US20100303773 Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activity and use thereof
12/02/2010US20100303765 Scaffoldless Constructs for Tissue Engineering of Articular Cartilage
12/02/2010US20100303760 Treatment and/or prevention of cancer and/or arthritis
12/02/2010US20100303758 Novel Glucocorticoid Receptor Agonists
12/02/2010CA2762620A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010CA2762137A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
12/02/2010CA2761639A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010CA2761597A1 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative
12/01/2010EP2256199A1 Therapeutic uses of BR43X2 soluble receptors
12/01/2010EP2256108A1 Substituted triazine kinase inhibitors
12/01/2010EP2255829A2 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient
12/01/2010EP2255801A1 Pharmaceutically active isoindoline derivatives
12/01/2010EP2254584A1 Biocompatible injectable products with zinc and/or zinc-form saccharide-salt release, and uses thereof
12/01/2010EP2155179B1 Axomadol for treating pain from arthritis
12/01/2010EP1932832B1 Triarylcarboxylic acid derivative
12/01/2010EP1644740B1 Assessment of skeletal growth using measurements of nt-cnp peptides
12/01/2010EP1244790B1 Nucleic acids encoding polypeptides having chips activity
12/01/2010CN1935192B Chinese medicine composition, and its preparing method and quality control method
12/01/2010CN1847261B Cyclic peptides as g-protein-coupled receptor antagonists
12/01/2010CN1646154B Albumin-fused anti-angiogenesis peptides
12/01/2010CN101903384A [1h-pyrazolo [3, 4-b] pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase C-theta
12/01/2010CN101903031A Human bone-forming cells in the treatment of inflammatory rheumatic diseases
12/01/2010CN101899444A Full-length polynucleotide sequence for coding chicken II-type collagen and application thereof
12/01/2010CN101899416A Recombinant rat myeloma cell NS0-F10 and application thereof
12/01/2010CN101899108A Novel polypeptide based on human TLR9 receptor functional domain segment LRR11 and applications thereof
12/01/2010CN101899106A Trimeric binding proteins for trimeric cytokines
12/01/2010CN101899047A Beta-amino tetrahydropyrazine, tetrahydropyrimidine and tetrahydropyridine used as dipeptidy peptidase inhibitors for curing or preventing diabetes
12/01/2010CN101898009A Medicinal bag for treating rheumatism
12/01/2010CN101897974A Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
12/01/2010CN101897970A Compositions and methods for treating diabetes
12/01/2010CN101897964A Medicament for preventing autoimmune disease
12/01/2010CN101897937A External lotion for treating rheumatic arthritis
12/01/2010CN101897934A External medicament for treating soft tissue injury and osteoarthrosis and preparation method thereof
12/01/2010CN101897928A Medicinal composition for treating ankylosing spondylitis and preparation method
12/01/2010CN101897897A Traditional Chinese medicine for treating cervical spondylosis
12/01/2010CN101897890A Chinese medicinal ointment for treating arthralgia and osteopatia sprain
12/01/2010CN101897879A Traditional Chinese medicine for treating rheumatic arthritis
12/01/2010CN101897862A Chinese medicinal paste for treating rheumatic pain
12/01/2010CN101897858A Rhizoma dioscoreae nipponicae frozen tissue active ingredient
12/01/2010CN101897853A External application Chinese medicinal bag for treating hyperosteogeny and dorsal disc prolapse and bridle used thereby
12/01/2010CN101897851A Traditional Chinese medicine for treating lumbar disc hemiation
12/01/2010CN101897836A External ointment for treating chalkstone
12/01/2010CN101897830A Traditional Chinese medicinal compound for treating rheumatism and preparation process thereof
12/01/2010CN101897827A Method for controlling quality of red medicinal gel
12/01/2010CN101897826A Traditional Chinese medicine for treating rheumatism
12/01/2010CN101897822A Traditional Chinese medicinal preparation for treating hyperosteogeny and prolapse of intervertebral discs and preparation method thereof
12/01/2010CN101897821A Granular preparation for promoting blood circulation, dredging collaterals and relieving pain and preparation method as well as quality control method thereof
12/01/2010CN101897810A Traditional Chinese medicine for treating traumatic injury of tendon and muscle
12/01/2010CN101897784A Chinese medicinal composition for treating gout and preparation method thereof
12/01/2010CN101897779A Medicated wine for auxiliary treatment of rheumatic arthritis
12/01/2010CN101897775A Traditional Chinese medicine for treating hyperosteogeny
12/01/2010CN101897770A Bone spur capsule and preparation process thereof
12/01/2010CN101897769A Traditional Chinese medicine for treating rheumatic arthritis
12/01/2010CN101897767A Urarthritis lavipeditum powder
12/01/2010CN101897766A Anti-inflammatory and analgesic medicine composition as well as preparation method and application thereof
12/01/2010CN101897763A Chinese medicinal pills for treating rheumatic lumbocrural pain
12/01/2010CN101897744A Medicament for eliminating phlegm and relieving asthma, preparation method thereof and use thereof
12/01/2010CN101897743A Chinese medicinal powder for treating cataclasis
12/01/2010CN101897724A Method for producing a soft tissue filler and method for producing an adipose tissue transplant
12/01/2010CN101897529A Medicament health-care pillow
12/01/2010CN101396369B Pharmaceutical use of sophoricoside
12/01/2010CN101361888B Traditional Chinese medicine for treating rheumatism and rheumatoid
12/01/2010CN101347477B Medicament composition for treating rheumatoid arthritis
12/01/2010CN101337920B Phenylalanyl pyrrolidine derivates, preparation method and application thereof
12/01/2010CN101337030B Medicine composition for reducing swelling and easing pain, preparation method and use thereof
12/01/2010CN101264256B Chinese medicine capsule for treating intractable pain
12/01/2010CN101239132B Strong bone-setting medicament for treating bone fracture and traumatic injury
12/01/2010CN101239131B Blood-stasis-dissipating blood-circulation-promoting fast fracture-setting medicament
12/01/2010CN101214335B Externally-applied emplastrum for treating hyperosteogeny, protrusion of lumbar disc and arthritis
12/01/2010CN101107252B Tetrahydrofurane derivatives for use as inhibitors of matrix metalloproteinases
12/01/2010CN101048165B Process for the preparation of ibandronate
11/2010
11/30/2010US7842787 Kinase insert domain-containing receptor (KDR) specific immunoglobulin for monitoring tumor angiogenesis
11/30/2010US7842784 Antagonizing bone morphogenetic protein activity; utilizing polypeptide comprising amino acids 22-452 of sequence 8; bone diseases, tissue regeneration, wound healing
11/30/2010US7842701 tyrosine kinase inhibitors such as 3-amino-2-(2-chloro-5-hydroxyphenyl)-7-(3-morpholin-4-ylpropoxy)-2,5-dihydro-4H-pyrazolo[4,3-c]quinolin-4-one, used as anticarcinogenic or antiproliferative agents
11/30/2010US7842669 administering to the site of the full thickness defect of articular cartilage, an osteochondral graft , an active growth factor e.g. purified bone morphogenetic protein (BMP) and a suitable carrier for the regeneration of the cartilage
11/30/2010US7842502 in vitro use of granulocyte chemotactic protein-2 (CXCL6) to promote cartilage (and underlying bone) formation e.g. in the repair of cartilage or osteochondral defects; osteoarthritis
11/30/2010US7842501 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/30/2010US7842097 Porous, biodegradable, three-dimensionally fixed matrix having shape retention; network of water insoluble biopolymer mineralized and bound with a cross-linked binder; promotes bone growth
11/30/2010CA2456817C Alkyne-aryl-naphthyridin-4 (1h)-one derivatives as type iv phosphodiesterase inhibitor
11/30/2010CA2299295C Substituted tetrahydropyrane derivatives and method for producing same
11/30/2010CA2295876C Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/25/2010WO2010135579A1 Fluorinated diaryl urea derivatives
11/25/2010WO2010135541A2 Variants of c-type natriuretic peptide
11/25/2010WO2010133793A1 Drug containing calcium and vitamin d
11/25/2010WO2010133707A1 Stabilized hyperforin solutions for oral administration
11/25/2010WO2010133087A1 Compositions and methods for treating inflammatory arthritis
11/25/2010WO2010082787A3 Pharmaceutical composition for bone-disease treatment or countering inflammation, comprising cartilage stem cells as an active principle
11/25/2010WO2010056585A3 Heteroaryl diamide compounds useful as mmp-13 inhibitors
11/25/2010US20100298447 Composite product of low-solubility drug and surfactant, and process for production thereof
11/25/2010US20100298427 Anti-inflammatory compositions and their use
11/25/2010US20100298402 Stilbene derivatives as pstat3/il-6 inhibitors
11/25/2010US20100298380 N-aryl-n-piperidin-4-ylmethyl-amide derivatives and thier use as monoamine neurotransmitter re-uptake inhibitors
1 ... 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 ... 820